Bibliometric analysis and recent trends on tyrosine kinase inhibitors in leukemia. [PDF]
Cheng J +5 more
europepmc +1 more source
Study of the association between HDAC8, SIRT1, and P53 gene expression with drug resistance in chronic myeloid leukemia patients. [PDF]
Mansouri R +4 more
europepmc +1 more source
Case Report: Management of a <i>BCR-ABL1</i>-positive high-risk rhabdomyosarcoma patient using tyrosine kinase inhibitors. [PDF]
Li F +7 more
europepmc +1 more source
Cracking the resistance code: The molecular reclassification of cancer and precision therapy strategies. [PDF]
Nikanjam M, Kurzrock R.
europepmc +1 more source
Imatinib and blinatumomab successfully rescued a pediatric B-ALL patient with TERF2::PDGFRB fusion resistant to dasatinib and chemotherapy. [PDF]
Ye F +5 more
europepmc +1 more source
Exploring the Allosteric Pathways of Asciminib in the Dual Inhibition of BCR-ABL1. [PDF]
Ming J, Gao H, Zhan J.
europepmc +1 more source
Phosphorylation-Inducing Molecules for Regulating Dynamic Cellular Processes. [PDF]
Pergu R +12 more
europepmc +1 more source
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1. [PDF]
Naumann N +14 more
europepmc +1 more source
Current Status of Molecularly Targeted Therapeutics in Blood Cancers. [PDF]
Kumala C, Vu L, Fandy TE.
europepmc +1 more source
Engineering of photo-inducible binary interaction tools for biomedical applications. [PDF]
Lee YT +8 more
europepmc +1 more source

